Pfizer Inc. (ETR:PFE)
21.42
-0.10 (-0.44%)
Aug 15, 2025, 5:35 PM CET
Pfizer Employees
Pfizer had 81,000 employees as of December 31, 2024. The number of employees decreased by 7,000 or -7.95% compared to the previous year.
Employees
81,000
Change (1Y)
-7,000
Growth (1Y)
-7.95%
Revenue / Employee
€672,611
Profits / Employee
€113,294
Market Cap
122.07B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 81,000 | -7,000 | -7.95% |
Dec 31, 2023 | 88,000 | 5,000 | 6.02% |
Dec 31, 2022 | 83,000 | 4,000 | 5.06% |
Dec 31, 2021 | 79,000 | 500 | 0.64% |
Dec 31, 2020 | 78,500 | -9,800 | -11.10% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 59,020 |
Bayer Aktiengesellschaft | 91,864 |
Fresenius SE & Co. KGaA | 176,486 |
Fresenius Medical Care AG | 111,513 |
Sartorius Aktiengesellschaft | 13,528 |
Fielmann Group AG | 24,363 |
Carl Zeiss Meditec AG | 5,730 |
Pfizer News
- 8 hours ago - Pfizer: This Is What Bulls Waited For - Seeking Alpha
- 21 hours ago - Pfizer's Investigational Drug Flunks Late-Stage For Sickle Cell Disease - Benzinga
- 1 day ago - Pfizer experimental sickle cell drug fails phase 3 trial - CNBC
- 1 day ago - Pfizer's sickle cell drug fails main goal in late-stage trial - Reuters
- 1 day ago - Pfizer fails in late-stage trial for sickle cell disease therapy - Seeking Alpha
- 1 day ago - After a Strong Quarterly Result, Is It Finally Safe to Buy Pfizer Stock Again? - The Motley Fool
- 1 day ago - Starboard takes new position in TripAdvisor, adds Salesforce and Pfizer among Q2 moves - Seeking Alpha
- 2 days ago - How Do Investors Really Feel About Pfizer? - Benzinga